Biogen (BIIB) Receivables - Net (2009 - 2026)

Biogen (BIIB) has reported Receivables - Net for 18 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Net fell 99.71% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (down 99.71% YoY), while the FY2025 annual figure was $524.6 million, up 6802.63% from the prior year.
• Receivables - Net came in at $4.7 million for Q1 2026 at Biogen, down from $524.6 million in the prior quarter.
• The five-year high for Receivables - Net was $1.7 billion in Q4 2022, with the low at $4.7 million in Q1 2026.
• Average Receivables - Net over 5 years is $908.7 million, with a median of $1.4 billion recorded in 2024.
• Across the five-year window, Receivables - Net jumped 8564.32% in 2025 and tumbled 99.71% in 2026, its largest moves.
• Year by year, Receivables - Net stood at $1.7 billion in 2022, then retreated by 2.4% to $1.7 billion in 2023, then dropped by 15.58% to $1.4 billion in 2024, then plunged by 62.66% to $524.6 million in 2025, then tumbled by 99.1% to $4.7 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $4.7 million, $524.6 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.